     |
Get the details on hundreds of startups per year, for only $495 annually.
MedMarket Diligence offers an online, searchable database of medtech company startups. Currently comprised of over 500 medical technology startup companies recently founded in the U.S. and outside the U.S., the Medtech Startup Companies Database is updated each month with 10 or more newly identified companies that have founded typically within the most recent one year period.
"Stealth" companies
Companies started weeks or even days ago
Many startups outside the U.S.
Data included are company name, contact, address, tel, fax, email, website, year founded, company summary, extended business description, clinical/technology category.
Records on existing companies in the database are reviewed on a regular basis to update company data. The companies in this database represent companies reported in the MedMarkets publication, with details as complete as possible on these frequently "stealth" companies, but also include other companies separately identified by MedMarket Diligence through research in its proprietary Reports and other research activities. Companies included span the medical device, biotech, biomaterial, pharmaceutical and other areas.
Subscribe to the Medtech Startups Database
Order Online
or by Order Form
Select a screenshot from the thumbnails below
|
|
|
|
|
Annual subscription:
- Single User License: $495
- Site License: $995 (unlimited #users per corporate site)
- Global License: $1,495 (unlimited #users per company worldwide)
Subscription to the database also includes
a monthly update on newly identified companies.Subscribe to the Medtech Startups Database:
You may also subscribe using this Order Form or by visiting our ONLINE store.
About the Database
The MedMarket Diligence Startups Database is compiled from multiple published and unpublished sources, including those in the public domain as well as sources that are proprietary to MedMarket Diligence.
MedMarket Diligence began tracking the formation of startup medical product companies in 2001, reporting on them within the regular “Startups” feature in the company’s MedMarkets publication. The companies included in Startups are those identified as medical product companies that had been founded typically no more than a year prior to the date research was being conducted.
The technology scope of companies covered is focused on medical device and related technologies, with “related” technologies to include biomaterials, biopharmaceuticals and others that are either being integrated with medical devices or competing with them directly. There is no strict limit to the clinical applications included. A company’s inclusion in the database is strictly based on the subjective decision of MedMarket Diligence and the availability of relevant state corporate filing or other appropriate records regarding the date of formation of the company. In instances in which companies state a specific filing date that differs from the corporate filing record for that company, the priority is given to the corporate filing record as an official date.
Upon formation of medical product startups, there are varying degrees to which companies actively engage in the process to either make themselves known or aggressively keep their technology and company details under wraps. The minimum necessary data on companies for them to be included in the database are:
Note: Inclusion or exclusion of a company in the database in no way constitutes an endorsement (or lack thereof) by MedMarket Diligence as to the company’s likely commercial success.
FAQs
Q: What are the sources for your information?
A: While we would love to provide you with all of our carefully cultivated information sources and methods so that you could do this yourself, we prefer that you focus on your business and let us help you by doing the footwork to find the startups. Suffice it to say, we pursue a wide range of public and private sources of information, often piecing together limited bits of information to reveal a company’s founding. Our sources change regularly and we are continually pursuing new sources and methods to identify new medtech companies.
Q: How often are new companies added to the database?
A: Every month, we add anywhere between five and ten newly identified startups. Most often, each startup added will fit a definition of having been founded within the past year, but we may add startups 1-2 years old if we find that they have been operating in stealth mode, have recently become known to us and are particularly interesting for the clinical application and/or market opportunity.
Q: If this is a “Startups” database, why are there companies over five years old?
A: The database includes companies founded 2001 or later that were identified as being less than a year old at the time of our research, at which point such companies arguably were startups. We include them now because we feel their technologies, which may still be under development or in any case have not yet penetrated the market, are still very much of interest to our customers.
Q: Why do some companies have limited details?
A: Some companies just don’t want particular details known so that they can ensure the proprietary nature of their development and/or ensure that they maximize the value of their product/technology to be “harvested” once they do make themselves known. While we respect their interest to be in stealth mode, we are in the business of assisting our customers identify such valuable companies and will therefore pursue every legitimate means possible to reveal details on these companies.
Q: Why isn’t there a classification as to whether a company’s products are device, biotech or drug?
A: First, we’ve determined that while at some point in the past there were relatively strong demarcations between such categories, the differences between these are rapidly dissolving as products straddle categories, variably act like one, then the other or otherwise refuse to be neatly grouped from a technology or other basis. Secondly, the distinction between these is less significant than is the clinical application of the products and technologies and what the target market may be, which is increasingly being penetrated by competing drugs, devices, biotech, hybrids of them and other product types.
Q: The company (or other source) says it was founded in a different year than is indicated in the database.
A: We typically report a company’s founding date (year) as the earlier of either the year the company reports or the year on record with the corporate filing (company’s corporate registration with a state registrar). If there is a discrepancy, it is often (though not always) that the company is reporting a later founding year than is on record, which artificially indicates a shorter development timeframe. We prefer to consistently report the earliest date we can find of the company’s actual formation.
Subscribe to the Medtech Startups Database ONLINE or by Order Form
Ó 2008, MedMarket Diligence, LLC. All Rights Reserved.
